These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34930785)

  • 1. CYP2C8-Mediated Formation of a Human Disproportionate Metabolite of the Selective Na
    Asano D; Hamaue S; Zahir H; Shiozawa H; Nishiya Y; Kimura T; Kazui M; Yamamura N; Ikeguchi M; Shibayama T; Inoue SI; Shinozuka T; Watanabe T; Yahara C; Watanabe N; Yoshinari K
    Drug Metab Dispos; 2022 Mar; 50(3):235-242. PubMed ID: 34930785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologically Based Pharmacokinetic Modeling for Quantitative Prediction of Exposure to a Human Disproportionate Metabolite of the Selective Na
    Asano D; Nakamura K; Nishiya Y; Shiozawa H; Takakusa H; Shibayama T; Inoue SI; Shinozuka T; Hamada T; Yahara C; Watanabe N; Yoshinari K
    Drug Metab Dispos; 2023 Jan; 51(1):67-80. PubMed ID: 36273823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of species differences in the metabolism of the selective Na
    Asano D; Shibayama T; Shiozawa H; Inoue SI; Shinozuka T; Murata S; Watanabe N; Yoshinari K
    Xenobiotica; 2021 Sep; 51(9):1060-1070. PubMed ID: 34330191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
    Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
    Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.
    Bidstrup TB; Bjørnsdottir I; Sidelmann UG; Thomsen MS; Hansen KT
    Br J Clin Pharmacol; 2003 Sep; 56(3):305-14. PubMed ID: 12919179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of tucatinib, a small molecule kinase inhibitor of HER2, is primarily governed by CYP2C8 enantioselective oxidation of gem-dimethyl.
    Sun H; Cardinal KA; Wienkers L; Chin A; Kumar V; Neace C; Henderson C; Endres CJ; Topletz-Erickson A; Regal K; Vo A; Alley SC; Lee AJ
    Cancer Chemother Pharmacol; 2022 Jun; 89(6):737-750. PubMed ID: 35435471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of DS-1971a, a Potent, Selective Na
    Shinozuka T; Kobayashi H; Suzuki S; Tanaka K; Karanjule N; Hayashi N; Tsuda T; Tokumaru E; Inoue M; Ueda K; Kimoto H; Domon Y; Takahashi S; Kubota K; Yokoyama T; Shimizugawa A; Koishi R; Fujiwara C; Asano D; Sakakura T; Takasuna K; Abe Y; Watanabe T; Kitano Y
    J Med Chem; 2020 Sep; 63(18):10204-10220. PubMed ID: 32392056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interspecies comparison and role of human cytochrome P450 and flavin-containing monooxygenase in hepatic metabolism of L-775,606, a potent 5-HT(1D) receptor agonist.
    Prueksaritanont T; Lu P; Gorham L; Sternfeld F; Vyas KP
    Xenobiotica; 2000 Jan; 30(1):47-59. PubMed ID: 10659950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.
    Baldwin SJ; Clarke SE; Chenery RJ
    Br J Clin Pharmacol; 1999 Sep; 48(3):424-32. PubMed ID: 10510156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity.
    Crouch RD; Morrison RD; Byers FW; Lindsley CW; Emmitte KA; Daniels JS
    Drug Metab Dispos; 2016 Aug; 44(8):1296-303. PubMed ID: 26936972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical scaling factor for predicting human pharmacokinetic profiles of disproportionate metabolites using the Css-MRTpo method and chimeric mice with humanised livers.
    Kamimura H; Uehara S; Yoneda N; Suemizu H
    Xenobiotica; 2023 Dec; 53(8-9):523-535. PubMed ID: 37938160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
    Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases.
    Illingworth NA; Boddy AV; Daly AK; Veal GJ
    Br J Pharmacol; 2011 Feb; 162(4):989-99. PubMed ID: 21054342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate.
    Li XQ; Björkman A; Andersson TB; Ridderström M; Masimirembwa CM
    J Pharmacol Exp Ther; 2002 Feb; 300(2):399-407. PubMed ID: 11805197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temsirolimus metabolic pathways revisited.
    Shokati T; Hartmann M; Davari B; Klawitter J; Klawitter J; Christians U
    Xenobiotica; 2020 Jun; 50(6):640-653. PubMed ID: 31596164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human cytochrome P450 enzymes involved in the metabolism of IN-1130, a novel activin receptor-like kinase-5 (ALK5) inhibitor.
    Kim YW; Kim YK; Kim DK; Sheen YY
    Xenobiotica; 2008 May; 38(5):451-64. PubMed ID: 18421620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive assessment of repaglinide metabolic pathways: impact of choice of in vitro system and relative enzyme contribution to in vitro clearance.
    Säll C; Houston JB; Galetin A
    Drug Metab Dispos; 2012 Jul; 40(7):1279-89. PubMed ID: 22451699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of the active carfentanil metabolite, 4-Piperidinecarboxylic acid, 1-(2-hydroxy-2-phenylethyl)-4-[(1-oxopropyl)phenylamino]-, methyl ester in vitro.
    Kong L; Walz AJ
    Toxicol Lett; 2022 Aug; 367():32-39. PubMed ID: 35835351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydrogenation of indoline by cytochrome P450 enzymes: a novel "aromatase" process.
    Sun H; Ehlhardt WJ; Kulanthaivel P; Lanza DL; Reilly CA; Yost GS
    J Pharmacol Exp Ther; 2007 Aug; 322(2):843-51. PubMed ID: 17502430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.